Recent Advances in Endometrial Cancer
- PMID: 28184290
- PMCID: PMC5288678
- DOI: 10.12688/f1000research.10020.1
Recent Advances in Endometrial Cancer
Abstract
Endometrial cancer is the most common gynecologic malignancy in the United States, with yearly rates continuing to increase. Most women present with early stage disease; however, advanced disease carries a grave prognosis. As a result, novel therapies are currently under investigation for the treatment of endometrial cancer. These advances include a better understanding of the genetic basis surrounding the development of endometrial cancer, novel surgical therapies, and new molecular targets for the treatment of this disease. This review explores the literature regarding these advancements in endometrial cancer.
Keywords: endometrial cancer; molecular targets; surgical therapies; treatment.
Conflict of interest statement
The authors declare that they have no competing interests. No competing interests were disclosed. No competing interests were disclosed.
References
-
- American Cancer Society: Cancer Facts & Figures 2016. Cancer Facts Fig 2016.2016;1–9. Reference Source
-
- SEER Stat Fact Sheets: Endometrial Cancer. 2016; Accessed April 10, 2016. Reference Source
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
